Cadila gets US nod for carvedilol tablets

MUMBAI, Sept 6 (Reuters) - Drug maker Cadila Healthcare Ltd (CADI.BO) said on Thursday it had received the U.S. Food and Drug Administration's approval for carvedilol tablets in multiple strengths.

The company launched the blood pressure drug in the United States on the first day of approval, Cadila said in a statement.

((Reporting by Bharghavi Nagaraju; editing by Sunil Nair; Reuters Messaging: bharghavi.nagaraju.reuters.com@reuters.net; +91 22 6636 9059)) Keywords: CADILA FDA/APPROVAL

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBOM226123